CDK9 as a Valuable Target in Cancer: From Natural Compounds Inhibitors to Current Treatment in Pediatric Soft Tissue Sarcomas

Cyclin-Dependent Kinases (CDKs) are well-known reliable targets for cancer treatment being often deregulated. Among them, since the transcription-associated CDK9 represents the sentry of cell transcriptional homeostasis, it can be a valuable target for managing cancers in which the transcriptional m...

Descripción completa

Detalles Bibliográficos
Autores principales: Cassandri, Matteo, Fioravanti, Rossella, Pomella, Silvia, Valente, Sergio, Rotili, Dante, Del Baldo, Giada, De Angelis, Biagio, Rota, Rossella, Mai, Antonello
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7438590/
https://www.ncbi.nlm.nih.gov/pubmed/32903585
http://dx.doi.org/10.3389/fphar.2020.01230

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7438590/
https://www.ncbi.nlm.nih.gov/pubmed/32903585
http://dx.doi.org/10.3389/fphar.2020.01230

Ejemplares similares